Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 14/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CMA1 | P23946 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30847625 | 0.77 | POLQ (0.54) | TACR1SLC6A4CMA1 | |
| SCHEMBL30847696 | 0.75 | POLQ (0.36) | TACR1SLC6A4 | |
| SCHEMBL30847690 | 0.71 | PER2 (0.35) | P2RX7 | |
| SCHEMBL30847754 | 0.71 | CACNA1H (0.36) | CMA1 | |
| SCHEMBL30847728 | 0.71 | POLQ (0.42) | TACR1SLC6A4CMA1 | |
| SCHEMBL30847777 | 0.68 | CMA1 (0.40) | ALDH1A1CMA1 | |
| SCHEMBL30847768 | 0.67 | POLQ (0.40) | TACR1CMA1 | |
| SCHEMBL30847628 | 0.67 | POLQ (0.44) | — | |
| SCHEMBL20768063 | 0.67 | CETP (0.42) | TACR1 | |
| SCHEMBL30847823 | 0.67 | TACR1 (0.43) | TACR1SLC6A4CMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598901-A1 | PYRROLIDINE AND IMIDAZOLIDINE BASED DNA POLYMERASE THETA INHIBITORS AND USE THEREOF | Thomas Jefferson University (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024076964-A1 | PYRROLIDINE AND IMIDAZOLIDINE BASED DNA POLYMERASE THETA INHIBITORS AND USE THEREOF | THOMAS JEFFERSON UNIVERSITY (US) | 2024-04-11 | — | — | WO | disclosed |